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• CBT when used with people who have autism is associated with a small or medium effect size.
• Effect size varied according to type of outcome measure used.
• Outcomes measured using self-report are associated with a small and non-signiﬁcant effect size.
• Outcomes measured using informant or clinician ratings are associated with either a small or medium effect size.
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Available online 04 August 2016The aims of this study were to undertake a meta-analytic and systematic appraisal of the literature investigating
the effectiveness of cognitive behavioural therapy (CBT)when usedwith individuals who have autistic spectrum
disorders (ASDs) for either a) affective disorders, or b) the symptoms of ASDs. Following a systematic search, 48
studies were included. CBT, used for affective disorders, was associated with a non-signiﬁcant small to medium
effect size, g = 0.24, for self-report measures, a signiﬁcant medium effect size, g = 0.66, for informant-report
measures, and a signiﬁcant medium effect size, g=0.73, for clinician-report measures. CBT, used as a treatment
for symptoms of ASDs,was associatedwith a small tomediumnon-signiﬁcant effect size, g=0.25, for self-report
measures, a signiﬁcant small to medium effect size, g=0.48, for informant-report measures, a signiﬁcant medi-
um effect size, g=0.65, for clinician-report measures, and a signiﬁcant small to medium effect size, g=0.35, for
task-basedmeasures. Sensitivity analyses reduced effect size magnitude, with the exception of that based on in-
formant-report measures for the symptoms of ASDs, which increased, g = 0.52. Deﬁnitive trials are needed to
demonstrate that CBT is an empirically validated treatment for use with people who have ASDs.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY license (http://
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Search terms.
Target
population
Autism Spectrum Disorder OR ASD OR Autis* OR Asperger* OR
Kanner* OR Pervasive Developmental Disorder
Intervention Cognitive Behavio* (Therap* OR Treatment OR Intervention) OR
Cognitive (Therap* OR Treatment OR Intervention) OR Behavio*
(Therap* OR Treatment OR Intervention) OR CBT OR
Psychotherap* OR Problem Solving
Combined
terms
1 AND 21. Introduction
Autism spectrum disorders (ASDs) are a range of
neurodevelopmental disorders characterised by difﬁculties with social
communication and interaction across contexts, as well as restricted
and repetitive patterns of behaviour, interests and activities. The pheno-
type incorporates a range of symptoms acrossmultiple domains, includ-
ing cognitive, behavioural, affective and sensory symptoms (Volkmar,
Paul, Klin, & Cohen, 2005;Wiggins et al., 2015). Sleeping and eating dif-
ﬁculties, synaesthesia, as well as affective dysregulation, and difﬁculties
with initiation, planning and organisation are often present
(Baron-Cohen, 2008; Wiggins et al., 2015). The prevalence amongst
4 year olds has been estimated to be approximately 13.4 per 1000
(Christensen et al., 2016), while the adult prevalence has been estimat-
ed to be 9.8 per 10,000 (Brugha et al., 2011).
There has been amarked increase in psychosocial interventions that
aim to treat the symptoms or features of ASDs. In the United Kingdom,
the National Institute for Health and Care Excellence (2012a) recom-
mended that people with ASDs should be offered age-appropriate psy-
chosocial interventions for comorbid mental health problems and the
core symptoms of ASDs. There are a large number of interventions
claiming to treat symptoms of ASDs, even though the evidence base is
poor (Matson, Adams, Williams, & Rieske, 2013). However, there is ev-
idence to support the use of applied behaviour analysis in the treatment
of symptoms of ASDs, and the authors of a Cochrane review concluded
that early and intensive behavioural interventions can lead to improve-
ments in adaptive, and communicative behaviour, aswell as social skills
(Reichow, Barton, Boyd, & Hume, 2012). Nevertheless, there are few
studies examining the effectiveness of these types of interventions
with adults, as opposed to children, with ASDs (Wright, Brooks,
D'Astous, & Grandin, 2013).
Alongside this, psychiatric comorbidity amongst peoplewith ASDs is
elevated (Green, Gilchrist, Burton, & Cox, 2000; Kim, Szatmari, Bryson,
Streiner, & Wilson, 2000; Lugnegård, Hallerbäck, & Gillberg, 2011;
Rescorla, 1986; Russell & Sofronoff, 2005), promptingmany to consider
how to adapt and deliver psychological therapies for children, adoles-
cents and adults with ASDs. Several meta-analytic or narrative reviews
involving studies that recruited samples of children and adolescents
have been completed in this area examining the effectiveness of cogni-
tive behavioural therapy (CBT) for anxiety disorders or social skills
training (Ho, Stephenson, & Carter, 2014, 2015; Kreslins, Robertson, &
Melville, 2015; Spain & Blainey, 2015; Sukhodolsky, Bloch, Panza, &
Reichow, 2013; Ung, Selles, Small, & Storch, 2014). While all of the
aforementioned studies have concluded that CBT and associated
interventions for anxiety amongst children with ASDs appear to be
promising, none have considered CBT across the lifespan. Further,none of the previously completed meta-analyses have: (a) considered
CBT, as opposed to applied behavioural analysis, when used as a treat-
ment for the actual symptoms or features of ASDs, rather than the treat-
ment of anxiety disorders, (b) included studies involving adult
participants, and (c) included other affective disorders, such as depres-
sion, alongside anxiety disorders. In order to address these weaknesses,
we completed a comprehensivemeta-analysis and systematic review of
the literature which aimed to investigate the effectiveness of cognitive
behavioural therapy across the lifespan for either (a) affective disorders
more broadly, while focusing on anxiety disorders as well, or (b) the
symptoms and features associated with ASDs. A supplementary aim
was to investigate whether there are differences in outcome for chil-
dren, adolescents and adults.2. Method
Relevant studies were identiﬁed by systematic searches of the fol-
lowing electronic databases: PsycINFO; MEDLINE; CINAHL Plus, Web
of Science, aswell asGoogle Scholar. The Cochrane Librarywas searched
to identify any existing systematic reviews. The key search terms and
how they were combined are found in Table 1. Terms were searched
using English and American terminology, spelling, and truncation to en-
sure that all variant word endings were identiﬁed. Alongside this, the
ancestry method was used to identify any further papers that may
have met eligibility criteria. The grey or fugitive literature was also
searched in an attempt to minimise publication bias. An initial search
was completed via http://www.opengrey.eu which includes research
reports, dissertations and conference papers. Dissertation Abstracts –
International and the Comprehensive Dissertation Index were also
searched, as well as trial registers. The ﬁnal search for studies was com-
pleted on 29 January 2016. The review was registered with PROSPERO,
an international database of systematic reviews in health and social
care, in order to provide transparency to the review process and to
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2.1. Eligibility criteria and study selection
Initially, titles and abstracts were screened for eligibility, and studies
were included if all of the following criteria were met: (a) participants
had a diagnosis of Autism Spectrum Disorder (or autistic disorder,
Asperger disorder, childhooddisintegrative disorder or pervasive devel-
opmental disorder not speciﬁed prior to the publication of DSM-V), and
diagnosis wasmade by a qualiﬁed clinician and/or using a standardised
diagnostic assessment; (b) studies used a control or comparison group
design, e.g. waiting list or treatment as usual (TAU), with or without
randomisation; (c) a clinician-led CBT intervention, either individual
or group-based, incorporating both cognitive and behavioural compo-
nents was used. Interventions in which CBT theory and principles
were utilised to teach or improve behavioural patterns, e.g. social skills,
were included, provided that this was explicitly stated; (d) use of at
least one validated and standardised outcome measure of either core
features of ASDs, i.e. difﬁculties in social interaction, impaired social
communication or restricted or repetitive patterns of behaviour and in-
terests, or co-occurring symptoms of mental disorder, e.g. anxiety, de-
pression, and (e) written in English.
Studies that aimed to treat affective disorders or symptoms of ASDs
were analysed separately for two reasons: (a) the “target” of the inter-
ventionwas separate in these studies,with one group focusing on trying
to treat symptoms of affective disorders, while the other attempted to
reduce difﬁculties or symptoms associated with having an ASD, and
(b) CBT for either incorporated psychoeducation, skills teaching, skills
practice, behavioural experiments, and cognitive restructuring. Howev-
er, the description of the interventions across studies was at times
sparse, and it was at times difﬁcult to ascertain the degree towhich cog-
nitive restructuring was used within some of the interventions. As a
consequence, itwas clear that the intervention incorporated both cogni-
tive and behavioural components for some studies, while for others, this
was less clear, although in all instances, the interventions were de-
scribed by the authors as using both cognitive and behaviouralmethods
However, it is important to bear inmind that CBT incorporates both cog-
nitive and behavioural components, although for some disorders there
is a clear focus on behavioural interventions (e.g. exposure and response
prevention) when delivering CBT. We excluded any studies that solely
made use of behavioural methods alone.
Studies were excluded if any of the following criteria were met: (a)
the methodology used was a single case, case series, qualitative, meta-
analysis or review articles; (b) the design of the study was such that
the effect of the CBT intervention could not be isolated from other treat-
mentmethods, e.g. psychotropic medication; (c), the primary interven-
tion was applied behavioural analysis or behaviour modiﬁcation, or
behavioural activation as a stand-alone treatment; and (d) the dataset
had been used within a previously included study to avoid double
counting of data (Senn, 2009). No limitswere applied to thedate of pub-
lication, age of participants orwhether the studyhas been published in a
peer review journal.
Studies that were non-randomised were not excluded. While this
represents an inherentweakness by increasing the risk of bias, the deci-
sion was made to include non-randomised studies at this stage consid-
ering the likelihood that few deﬁnitive (Phase III) trials within this area
have been completed.
Following the removal of duplicate studies, the systematic search of
the electronic databases returned 2332 potentially eligible studies. Fol-
lowing an initial screen of the titles and abstracts, 2263 were excluded.
In addition to the remaining 69 studies, a further 102 were identiﬁed
using the ancestry method, and two were located from searching the
grey literature. The resulting total number of papers retrieved was
173, six of which were protocols. The authors of protocols were
contacted directly to try to source outcome data; two of these researchgroups provided data, while the remaining four did not respond and
were excluded. A further 107 papers were excluded because they did
not include a comparison or control group, ﬁve were excluded because
they hadmade use of a pre-existing dataset that had been previously in-
cluded, four were excluded because they did not include cognitive-be-
havioural components within the intervention, one was excluded due
to a lack of validated or standardised outcome measures, one was ex-
cluded because the effects of CBT could not be isolated and one was ex-
cluded because we were unable to trace the paper.
The remaining 50 studies met the eligibility criteria, although two
studies were excluded at this stage because the published datawere in-
sufﬁcient andwe could not calculate effect sizes; the authors did not re-
spond to our request for further data (DeRosier, Swick, Davis, McMillen,
& Matthews, 2011; Provencal, 2003). Forty-eight studies, involving
2099 participants (1081 CBT, 1018 control) were therefore included in
the quantitative synthesis. Fig. 1 depicts a PRISMA ﬂow diagram
(Moher, Liberati, Tetzlaff, & Altman, 2009), outlining the identiﬁcation,
screening and inclusion or exclusion of articles throughout the process.
Reasons for article rejection are clearly indicated. The eligibility criteria
were applied by two authors (LW & PL) independently, and inter-rater
reliability was excellent, 96.5%, k= 0.92, 95% CI [0.85, 0.98].
2.2. Data analysis
The standardisedmean difference (SMD) was calculated to estimate
the difference between the treatment and control conditions. Cohen's d
was transformed into Hedge's g (Hedges, 1981) using correction factor J
to correct for possible positive bias due to small sample sizes. The mag-
nitude of Hedge's g was interpreted using Cohen's convention as small
(0.2), medium (0.5), and large (0.8). The variance and standard error
of g for each study was calculated. As outcome measures may take the
form of self-, clinician- or informant-reports, and there is evidence to
suggest that people with ASD may have difﬁculties with judging their
own social or communicative behaviour (Baron-Cohen, Jolliffe,
Mortimore, & Robertson, 1997) effect sizes were calculated individually
for each type of outcome measure where possible (i.e. outcome mea-
sures were grouped as either self-report, informant-report, clinician-re-
port, or task-based, where participants were invited to complete a task,
such as an emotion recognition task using faces). In this context, an in-
formant-based outcomemeasure was a rating of clinical symptomatol-
ogy provided by a third party who was not the clinician or the
participant. Often, this person was a family member.
The analysis was undertaken using RevMan Version 5.3. A random
effects model was used for the following reasons: (a) heterogeneity
was anticipated as data came from a variety of sources and we could
not assume a common effect size; and (b) inferences made from ran-
dom effects models are unconditional and can be applied to a popula-
tion of studies larger than the sample.
Heterogeneity was thought to be associated with whether CBT
was delivered as a group or individually, the age range of partici-
pants, and symptom severity. This was explored using the I2 statistic,
which describes the percentage of variation across studies due to
heterogeneity, rather than chance (Higgins & Thompson, 2002).
The I2 statistic has been chosen rather than Cochran's Q since it
enables quantiﬁcation of the effect of heterogeneity, providing a
measure of the degree of inconsistency in results (Higgins &
Thompson, 2002), and it does not inherently depend on the number
of studies included in the meta-analysis (Higgins, Thompson, Deeks,
& Altman, 2003). The degree and impact of heterogeneity was
assessed using the categorisation of low (25%), medium (50%) and
high (75%), in addition to a quality assessment of the methodology
(Higgins et al., 2003). A sensitivity analysis was also undertaken.
Outliers were removed and the weighted mean effect size was
recalculated. Publication bias was assessed graphically using funnel
plots, plotting summary effect size against standard error (Light &
Pillemer, 1984); a skewed and asymmetrical plot may indicate a
Fig. 1. PRISMA Flow diagram depicting study selection.
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(Rosenthal, 1991) was used to assess the impact of bias by calculat-
ing an estimate of the number of new studies averaging a null result
that would be required to bring the overall treatment effect to non-
signiﬁcance. A ﬁgure exceeding 5n + 10 would indicate that the re-
sults could be considered robust to the effects of publication bias
(Rosenthal, 1991).
2.3. Quality appraisal
Quality appraisal of included studieswas undertaken by two authors
(LW & PL) independently using the National Institute for Health and
Care Excellence Quality Appraisal Checklist for Quantitative Interven-
tion Studies (National Institute for Health and Care Excellence, 2012b),
bearing inmind that the use of such scales has been criticised in the Pre-
ferred Reporting Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidance (Liberati et al., 2009). There was ‘moderate’ agree-
ment between the two authors for internal validity, 72.0%; k = 0.48;
95% CI [0.26, 0.71], and ‘good’ agreement for external validity, 84.0%;
k= 0.66; 95% CI [0.45, 0.86].3. Results
3.1. Quality appraisal
The key characteristics of the 50 included studies are found in Ap-
pendix A, while the summary quality appraisal ratings for each study
are found in Appendix B. A persistent problem across all studies was
small sample size, contributing to reduced power. Freitag et al. (2015)
included the highest number of participants (101 CBT, 108 control),
whilst eight of the studies included in the quantitative synthesis in-
volved less than ten participants per group. Several of these studies
were deﬁned by the authors as pilot or feasibility trials. However, a
number of studies that were not called pilot or feasibility trials, were
in fact lower in quality and had smaller sample sizes than many clearly
deﬁned pilot or feasibility trials. Quality appraisal and risk of bias were
therefore considered on a study by study basis and sensitivity analysis
was conducted by removing studies deemed to be at high risk of bias,
rather than those labelled as pilot or feasibility trials.
Other common problems included the lack of reporting on partici-
pant engagement within intervention sessions, poor reporting on
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studies reported adequate allocation concealment and ten of the studies
included in meta-analysis were non-randomised, contributing to a high
risk of allocation bias. Due to the nature of the interventions involved, it
is not possible for investigators to blind participants (and often infor-
mants) to intervention allocation. However, blinding of outcome asses-
sors was possible but was not conducted in the majority of studies,
contributing to detection bias.
A ﬁnal common difﬁculty across studies was failure to specify a pri-
mary outcomemeasure. This complicated themeta-analysis, particular-
ly in studieswhere a high number of outcomemeasureswere utilised or
different measures were used to assess a range of constructs, because
we were left to make the decision as to which outcome measure to
use within our meta-analysis. We made this decision based upon the
predominant hypothesis or research question under investigation. For
example, where a study aimed to investigate the effectiveness of an in-
tervention for social skills, we chose the instrument that was used to
measure social skills so that the study could be included in our meta-
analysis. In some circumstances, researchers made use of more than
one measure which was associated with the predominant hypothesis;
in these instances, we chose the most commonly used measure across
studies in an attempt to reduce heterogeneity. Where there were no
commonalities across studies, the authors did not specify their primary
outcome measure, and there were multiple measures used, we chose
the primary outcomemeasure at random. The lack of measures validat-
ed for usewith individualswith ASDwasnoted, although this is clearly a
wider issue that needs attention.
3.1.1. Cognitive behavioural therapy for affective disorders
Twenty-four of the included studies aimed to examine the effective-
ness of CBT for affective disorders, with the bulk attempting to treat
anxiety disorders, with others targeting depression or emotion regula-
tion difﬁculties. Seventeen of these studies involved children and ado-
lescents, whilst four included adult participants. Three studies
included both adolescent and adult participants and were therefore
assigned to a ‘Mixed Age’ subgroup for analysis (McGillivray & Evert,
2014; Pahnke, Lundgren, Hursti, & Hirvikoski, 2014; Russell et al.,
2013). Fifteen of the 24 studies examined group-based CBT, whilst
eight reported on individual CBT. The remaining study involved 21
group sessions, as well as three individual sessions (Langdon et al.,
2016, 2013). Since this studywas predominantly group-based, the deci-
sion was made to include it in the ‘group-based’ subgroup when
analysing mode of CBT delivery.
The majority of studies targeted anxiety (15 of the 24 studies). As
thiswas such a large group, a subgroup analysiswas conducted to assess
potential variations of treatment effects across age groups within this
subset of studies. This included studies investigating the treatment of
anxiety disorders that had been included in earlier meta-analytic work
(Sukhodolsky et al., 2013; Ung et al., 2014), but also included additional
studies; two studies targeted symptoms of obsessive compulsive disor-
der (Russell et al., 2013; Russell, Mataix-Cols, Anson, & Murphy, 2009)
were also included within this subset, as was a study investigating de-
pression, anxiety and rumination (Spek, van Ham, & Nyklíček, 2013)
and a study investigating depression, anxiety and stress (McGillivray
& Evert, 2014). In the latter two studies, only outcomes pertaining spe-
ciﬁcally to anxiety were used to reduce heterogeneity within the quan-
titative synthesis as much as possible. In total, 19 studies were included
within the anxiety subset. Of the remaining ﬁve studies, one targeted
anger (Sofronoff, Attwood, Hinton, & Levin, 2007), one targeted general
emotional regulation skills (Scarpa & Reyes, 2011), one targeted insom-
nia (Cortesi, Giannotti, Sebastiani, Panunzi, & Valente, 2012), one
targeted self-esteem, quality of life and sense of coherence
(Hesselmark, Plenty, & Bejerot, 2014) and one targeted stress and emo-
tional distress (Pahnke et al., 2014).
Fourteen studieswere deﬁned as randomised controlled trials, seven
ofwhich compared a CBT interventionwith awaitlist control group, andthree compared CBT to treatment as usual. Three randomised controlled
trials comparedCBT to a non-CBTgroup-based treatment: either a social
recreational program (Hesselmark et al., 2014; Sung et al., 2011) or an
anxiety management group (Russell et al., 2013). The ﬁnal randomised
controlled trial (Cortesi et al., 2012) compared a CBT group to a group
which received a placebo drug. This study also included a condition in
which participants received melatonin and a condition in which partic-
ipants received both melatonin and CBT. Participants from these inter-
vention arms were not included as the use of a drug-based
comparison group was not utilised in any other included study.
Three of the 24 studies investigating CBT for the treatment of affec-
tive disorders were quasi-experimental or non-randomised (Clarke,
2012; McGillivray & Evert, 2014; van Steensel, Dirksen, & Bögels,
2014), whilst seven were called pilot studies. Three of the seven pilot
studies within this group were randomised, whilst four were not, and
six compared a CBT intervention to a waitlist control group, whilst one
compared CBT to treatment as usual.
As anticipated, there was extensive variation in the outcome mea-
sures used across studies. Many studies included outcome measures
from various sources, with the most common report type being self-re-
port within studies targeting co-occurring symptoms of affective disor-
der, followed closely by informant-report (usually parent) outcomes
and clinician-rated outcomes. Only one study within this group used a
task-based outcome measure (Cortesi et al., 2012). There was also con-
siderable variation in the intensity and content of intervention. The
number of sessions ranged from four to 50,whilst the length of each ses-
sion ranged from 40 to 180 min. The majority of studies used a struc-
tured protocol (22 out of 24), with 21 of the studies utilised
“traditional” CBT methods, with common components including role
play, exposure and teaching/ rehearsal of emotional regulation skills.
Common adaptations to CBT included an increased emphasis on behav-
ioural rather than cognitive components, the use of social stories and vi-
gnettes and increased involvement of family members. One of the
studies (Hepburn, Blakeley-Smith,Wolff, & Reaven, 2015) piloted a vid-
eoconferencing CBT intervention designed for delivery in a small, multi-
family group format, whilst another study (Spek et al., 2013) used a
modiﬁed version of Mindfulness Based Therapy with cognitive ele-
ments omitted. Another used a modiﬁed Acceptance and Commitment
Therapy protocol and participants in the CBT group engaged in daily
mindfulness exercises in addition to structured intervention sessions.
3.1.2. Cognitive behavioural therapy for ASD
There were 24 included studies that examined the effectiveness of
CBT for symptoms or features of ASD. One study investigated both the
effect of CBT on social skills and anxiety (White et al., 2013) and the out-
comes pertaining to social skills were included in themeta-analysis. An-
other intervention study focused upon both social communication and
anxiety, but the ﬁndings were reported in two separate papers (Fujii
et al., 2013; Wood, Fujii, Renno, & Van Dyke, 2014); the decision was
made to exclude Fujii et al. (2013) as inclusion would have led to the
double counting of data. Provencal (2003) and DeRosier et al. (2011)
were excluded as attempts to obtain data required to calculate effect
sizes were unsuccessful.
Themajority of studies targeted social skills (18 of the 24 studies in-
cluded in quantitative synthesis), while of the remaining six studies,
four targeted Theory of Mind (Begeer et al., 2011, 2015; Ozonoff &
Miller, 1995; Solomon, Goodlin-Jones, & Anders, 2004), one targeted af-
fectionate communication (Andrews, Attwood, & Sofronoff, 2013) and
one targeted the perception of facial emotions (Baghdadli et al., 2013).
A number of studies targeted both social skills and aspects of social cog-
nition. In these circumstances, the primary outcome measure was in-
cluded, but there was extensive variation in outcome measures across
studies. In situations in which the primary outcome measure was not
speciﬁed, only outcome measures pertaining to social skills were in-
cluded to avoid comparisons of different constructs across report
types. The most common type of outcome measure was informant-
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effectiveness of CBT for affective disorders, seven studies within this
group utilised a task-basedmeasures, for example Theory ofMind tasks.
Fourteen of the studies were randomised controlled trials, one of
which is the only Phase III trial in this area to date (Freitag et al.,
2015). This study compared CBT to treatment as usual, whilst thirteen
of the RCT's compared a CBT intervention with a waitlist control
group. The ﬁnal RCT (Soorya et al., 2015) compared CBT to a facilitated
play active control group. Three of the remaining ten studies were
quasi-experimental or non-randomised, and seven were labelled pilot
studies. These studies were included in the initial analysis but the
quasi-experimental studies involved a variety of control groups:
Ozonoff and Miller (1995) compared CBT to no treatment, Laugeson,
Frankel, Gantman, Dillon, and Mogil (2012) used a waitlist control
group and Laugeson, Ellingsen, Sanderson, Tucci, and Bates (2014) and
Laugeson and Park (2014) reported the use of an active control group
based on a non-CBT social skills curriculum (“Superskills”,
Coucouvanis, 2004). Three pilot studies used a waitlist control group,
two compared CBT to treatment as usual and one compared CBT to
“no intervention” (Koning, Magill-Evans, Volden, & Dick, 2013). The re-
maining study reported the use of an active control group with sessions
consisting predominantly of leisure activities (Baghdadli et al., 2013).
Six of the seven pilot studieswithin this groupwere randomised, whilst
the remaining study was quasi-experimental (Turner-Brown, Perry,
Dichter, Bodﬁsh, & Penn, 2008).
There was considerable variation in the intensity and content of in-
tervention. The number of sessions ranged from ﬁve (Andrews et al.,
2013) to 70, with Laugeson et al. (2014) reporting on an intervention
in which children received 30 minute sessions ﬁve days per week over
a period of 14 weeks. The length of each session ranged from 30 min
to whole day sessions. The majority of studies investigating the effec-
tiveness of CBT for core features of ASD used a structured protocol (22
out of 24). In terms of treatment content, studies within this group
less commonly reported “traditional” CBT methods. Some studies did
not directly refer to cognitive behavioural therapy per se, but they ex-
plicitly mentioned the inclusion of both cognitive and behavioural tech-
niques in the intervention, and therefore met inclusion criteria for the
current study. Content commonly included direct social skills teaching
and role play, emotional identiﬁcation work and problem-solving exer-
cises or discussions. Common adaptations included increased use ofFig. 2. Forest plot showing estimated treatment effect of CBT for symptosocial stories and vignettes, increased use of role play and the involve-
ment of family members in intervention sessions and homework
activities.
3.2. Effectiveness of CBT for reducing symptoms of affective disorders
3.2.1. Self-report outcome measures
Seventeen studies, including 645 participants (329 CBT, 316 con-
trol), included self-reported outcomemeasures. One study utilised a rel-
evant self-reported outcomemeasure but it was not possible to include
this in the analysis as an attempt to obtain the data necessary to calcu-
late the effect size was unsuccessful (Storch et al., 2013). The outcome
measures used varied considerably across studies. A random-effects
meta-analysis of these trials indicated a small to medium but non-sig-
niﬁcant effect favouring CBT over waiting-list, treatment as usual or ac-
tive control as reported by participants, g= 0.24; 95% CI [−0.05, 0.53],
z=1.6, p=0.11, (Fig. 2). The analysis revealed a signiﬁcant amount of
heterogeneity, with I2 indicating that 69% of the variability in estimated
treatment effect was due to heterogeneity rather than chance, p b 0.001.
As one study, had a SMD (g = 2.64) considerably higher than the
other included studies, g ranged from−0.39 to 0.85, a sensitivity anal-
ysis was conducted and this outlier was removed (Chalfant, Rapee, &
Carroll, 2007). Exclusion of this study resulted in no signiﬁcant treat-
ment effect, g= 0.10; 95% CI [−0.06, 0.27], z = 1.21, p= 0.23, and I2
reduced markedly to 4%, p= 0.41, indicating the considerable impact
that the inclusion of this study had on the pooled SMD. A further sensi-
tivity analysis to remove studies deemed to be at a high risk of bias
(Clarke, 2012; Hesselmark et al., 2014; McGillivray & Evert, 2014;
Reaven et al., 2009; Russell et al., 2009) resulted in a very similar effect,
g= 0.09; 95% CI [−0.12, 0.30], z= 0.84, p= 0.40.
Eleven studieswere includedwithin our sub-group analysis focusing
on the treatment of anxiety disorders using self-report measures. A ran-
dom effects meta-analysis of these trials revealed a non-signiﬁcant
small to medium effect size, g = 0.32; 95% CI [−0.10, 0.75], z = 1.50,
p= 0.13. The analysis revealed a signiﬁcant amount of heterogeneity,
with I2 indicating that 77% of the variability in estimated treatment ef-
fectwasdue to heterogeneity rather than chance, p b 0.001. To complete
our sensitivity analysis, Chalfant et al. (2007) was removed as it was
judged to an outlier, which reduced the effect size to g = 0.08; 95% CI
[−0.12, 0.29], z= 0.79, p= 0.43, I2 = 0%, p= 0.63. We removed twoms of affective disorders in ASD based on self-reported outcomes.
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al., 2009) reduced the effect size further, g=0.01; 95% CI [−0.21, 0.24],
z= 0.12, p= 0.90, I2 = 0%, p= 0.78.
The remaining six studies involved using CBT in the treatment of
OCD (Russell et al., 2013, 2009), depression, aswell as anxiety and rumi-
nation (Spek et al., 2013), self-esteem (Hesselmark et al., 2014), stress
and emotional distress (Pahnke et al., 2014), depression, as well as anx-
iety and stress (McGillivray & Evert, 2014). Collectively, these studies
were associated with a non-signiﬁcant small effect size, g= 0.12; 95%
CI [−0.23, 0.46], z = 0.66, p = 0.51. However, heterogeneity was not
signiﬁcant, I2 = 41%, p = 0.13 (Fig. 2). Removal of three studies judged
to be at high risk of bias (Russell et al., 2009; Hesselmark et al., 2014;
McGillivray & Evert, 2014) increased the effect size to g= 0.27; 95% CI
[−0.39, 0.94], z= 0.81, p= 0.42, I2 = 66%, p= 0.05.
3.2.2. Informant-report outcome measures
Sixteen studies, including 620 participants (325 CBT, 295 control),
made use of informant-reported outcomemeasures. One study utilised
a relevant informant-reported outcome measure but was excluded be-
cause we did not obtain the data necessary to calculate the effect size
(Pahnke et al., 2014). The outcome measures used varied considerably
across studies. The meta-analysis of these trials indicated a signiﬁcant
medium effect favouring CBT over waiting-list, treatment as usual or ac-
tive control as reported by informants, g=0.66; 95% CI [0.29, 1.03], z=
3.49, p b 0.001, (Fig. 3). The analysis indicated a signiﬁcant amount of
heterogeneity, with I2 indicating that 78% of the variability in estimated
treatment effect was due to heterogeneity rather than chance, p b 0.001.
Again, Chalfant et al. (2007) had a SMD, g = 4.27, considerably
higher than the other included studies, g ranged from−0.39 to 1.21,
and a sensitivity analysis was therefore conducted to remove this outli-
er. Exclusion of this study resulted in a lower treatment effect, g=0.47;
95% CI [0.25, 0.69], z=4.17, p b 0.001, although it remained statistically
signiﬁcant. I2 reduced to 38%, p=0.07, again indicating the impact that
the inclusion of this study had on the pooled SMD. A further sensitivity
analysis to remove studies deemed to be at a high risk of bias (Clarke,
2012; Hepburn et al., 2015; Reaven et al., 2009; Scarpa & Reyes, 2011)
resulted in a very similar effect, g= 0.45; 95% CI [0.18, 0.72], z= 3.24,
p= 0.001.
Focusing only on the twelve studies that aimed to treat anxiety, our
meta-analysis revealed that CBT was associated with a large effect size,Fig. 3. Forest plot showing estimated treatment effect of CBT for symg=0.80; 95% CI [0.34, 1.25], z=3.42, p b 0.001 (Fig. 3). The analysis in-
dicated a signiﬁcant amount of heterogeneity, I2= 80%, p b 0.001. A fur-
ther sensitivity analysis, with Chalfant et al. (2007) removed reduced
the effect size to g = 0.49; 95% CI [0.29, 0.70], z = 4.74, p b 0.001,
I2 = 2%, p = 0.42. Removal of studies judged to be at high risk of bias
(Clarke, 2012; Reaven et al., 2009; Hepburn et al., 2015) led to a further
reduction in effect size, g=0.46; 95% CI [0.20, 0.72], z=3.46, p b 0.001,
I2 = 22%, p= 0.25.
The remaining four studiesmaking use of informant-ratings focused
on CBT as a treatment for anger (Sofronoff et al., 2007), emotion regula-
tion, including anger and anxiety (Scarpa & Reyes, 2011), insomnia
(Cortesi et al., 2012), or OCD (Russell et al., 2013). Collective, they
were associated with a small to medium non-signiﬁcant effect size,
g=0.28; 95% CI [−0.39, 0.96], z=0.82, p=0.41. A signiﬁcant amount
of heterogeneity was also found, I2 = 75%, p b 0.001. We removed
Scarpa and Reyes (2011) as this study was deemed to be at a high risk
of bias and the effect size increased, g = 0.36; 95% CI [−0.44, 1.16],
z= 0.88, p= 0.38, I2 = 83%, p b 0.05.
3.2.3. Clinician-rated outcome measures
Thirteen studies, including 514 participants (262 CBT, 252
control), made use of clinician-rated outcome measures, but there
was substantial variation in the type of choice of measure. Two of
these studies presented dichotomous data (Chalfant et al., 2007;
van Steensel et al., 2014). In order to include these studies in a ran-
dom-effects meta-analysis, the odds ratio was calculated and re-
expressed as a SMD (Chinn, 2000). A random-effects meta-analysis
using the Generic Inverse Variance method was conducted as esti-
mates of effect were calculated for the two aforementioned studies.
The analysis indicated a signiﬁcant medium effect favouring CBT
over waiting-list, treatment as usual or active control as rated by cli-
nicians, g=0.73; 95% CI [0.38, 1.08], z= 4.05, p b 0.001, (Fig. 4). The
analysis again indicated a signiﬁcant amount of heterogeneity, with
I2 indicating that 69% of the variability in estimated treatment effect
was due to heterogeneity rather than chance, p b 0.001.
Two studies (Chalfant et al., 2007; Wood et al., 2009) had a SMD,
g = 2.51 and g = 2.47 respectively, considerably higher than the
other included studies, g ranged from−0.31 to 1.38, and a sensitivity
analysis was conducted to remove these outliers. Exclusion of these
studies resulted in a lower treatment effect, g = 0.52; 95% CI [0.27,ptoms of affective disorders on informant-reported outcomes.
Fig. 4. Forest plot showing estimated treatment effect of CBT for symptoms of affective disorders on clinician-rated outcomes.
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reduced to 36%, p=0.11, again indicating the impact that the inclusion
of these studies had on the pooled SMD. A further sensitivity analysis to
remove studies deemed to be at a high risk of bias (Russell et al., 2009;
van Steensel et al., 2014) resulted in a very similar effect, g=0.59; 95%
CI [0.33, 0.85], z= 4.48, p b 0.001.
Turning to consider only anxiety, based on clinician-rated outcomes,
CBT was associated with a signiﬁcant large effect size, g= 0.86; 95% CI
[0.47, 1.24], z=4.37, p b 0.001, across the eleven included studies. Het-
erogeneity was high, I2 = 69%, p b 0.001, (Fig. 4). We removed Chalfant
et al. (2007), and this decreased the effect size, g= 0.60; 95% CI [0.34,
0.86], z = 4.59, p b 0.001, I2 = 27%, p = 0.20, while removing studies
judged tobe at high risk of bias (vanSteensel et al., 2014) then increased
the effect size, g=0.63; 95% CI [0.34, 0.92], z=4.25, p b 0.001, I2=35%,
p= 0.15.
The remaining two studies both investigated CBT as a treatment for
OCD (Russell et al., 2013, 2009) and these were associated with a non-
signiﬁcant small effect size, g = 0.08; 95% CI [−0.57, 0.72], z = 0.23,
p= 0.82.3.2.4. Task-based outcome measures
As only one study made use of this type of outcomemeasure, if was
not possible to calculate the pooled SMD.Fig. 5. Forest plot showing estimated treatment effect of CBT for3.3. Effectiveness of CBT for symptoms associated with autism
3.3.1. Self-report outcome measures
Nine studies (370 participants; 192 CBT, 178 control), investigated
the effectiveness of CBT in treating symptoms associated with ASD
and included appropriate self-reported outcomemeasures. As indicated
in Fig. 5, a random-effectsmeta-analysis of these trials indicated a small,
but non-signiﬁcant effect favouring CBT over waiting-list, treatment as
usual or active control, as reported by participants, g = 0.25; 95% CI
[−0.03, 0.53], z=1.77, p=0.08. Heterogeneity was not signiﬁcant, al-
though I2 indicated that 40% of the variability in estimated treatment ef-
fect was due to heterogeneity rather than chance, p=0.10. A sensitivity
analysis to remove studies deemed to be at a high risk of bias (Gantman,
Kapp, Orenski, & Laugeson, 2012; Laugeson et al., 2012; Turner-Brown
et al., 2008) resulted in no signiﬁcant treatment effect, g = 0.10; 95%
CI [−0.24, 0.45], z= 0.58, p= 0.56.
3.3.2. Informant-report outcome measures
Eighteen studies (950 participants; 480 CBT, 470 control) were in-
cluded in this analysis revealing a signiﬁcant small effect favouring
CBT over waiting-list, treatment as usual or active control as reported
by informants, g=0.48; 95% CI [0.30, 0.65], z=5.39, p b 0.001. Hetero-
geneity was not signiﬁcant, although I2 indicated that 36% of the vari-
ability in estimated treatment effect was due to heterogeneity rathersymptoms related to ASD based on self-reported outcomes.
Fig. 6. Forest plot showing estimated treatment effect of CBT for symptoms related to ASD based on informant-reported outcomes.
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to be at a high risk of bias (Gantman et al., 2012; Ichikawa et al., 2013;
Koning et al., 2013; Laugeson et al., 2012) resulted in a slightly larger
medium treatment effect, g = 0.52; 95% CI [0.34, 0.70], z = 5.63,
p b 0.001, with a small reduction in heterogeneity, I2 = 33%, p= 0.12
(Fig. 6).3.3.3. Clinician-rated outcome measures
Six studies, including 153 participants (79 CBT, 74 control) were
included. One of these studies presented the outcome as dichoto-
mous data, and therefore the odds ratio was calculated and
expressed as a SMD (Koenig et al., 2010); the generic inverse vari-
ance method the estimate of effect was calculated. The analysis indi-
cated a signiﬁcant “medium” effect favouring CBT over waiting-list,
treatment as usual or active control as rated by clinicians, g = 0.65;
95% CI [0.10, 1.21], z = 2.30, p = 0.02 (Fig. 7). Heterogeneity was
non-signiﬁcant, although I2 indicated that 47% of the variability in
estimated treatment effect was due to heterogeneity rather than
chance, p = 0.10.
One study had a SMD, g = 2.43 (Koenig et al., 2010), considerably
higher than the other included studies, g ranged from 0.08 to 1.51. Re-
moving this outlier resulted in a lower treatment effect, g= 0.47; 95%
CI [0.09, 0.85], z=2.40, p=0.02, although it remained statistically sig-
niﬁcant. I2 reduced to 1%, p= 0.40, indicating the considerable impact
that the inclusion of this study had on the pooled SMD. A further sensi-
tivity analysis to remove studies deemed to be at a high risk of bias
(Ichikawa et al., 2013; Turner-Brown et al., 2008;Wood et al., 2014) re-
sulted in a very similar but lower and non-signiﬁcant treatment effect,
g = 0.44; 95% CI [−0.01, 0.89], z = 1.90, p = 0.06. It is highly likely
that this is related to the fact that the exclusion of the above studies
left only two studies in the analysis, and as such, this analysis should
be interpreted with marked caution.Fig. 7. Forest plot showing estimated treatment effect of CBT for3.3.4. Task-based outcome measures
Seven studies, incorporating 237 participants (117 CBT, 120 con-
trol), were included in this analysis, which revealed a signiﬁcant small
effect in favour of CBT over waiting-list, treatment as usual or active
control on task-based measures, g = 0.35; 95% CI [0.09, 0.61], z =
2.67, p = 0.008 (Fig. 8). Heterogeneity was not an issue, I2 = 0%, p =
0.58. Removing studies deemed to be at a high risk of bias (Baghdadli
et al., 2013; Koning et al., 2013; Ozonoff & Miller, 1995; Solomon et
al., 2004) resulted in a very similar non-signiﬁcant effect size, g =
0.30; 95% CI [−0.12, 0.72], z= 1.42, p= 0.16. Again, it is highly likely
that this is related to the fact that the exclusion of the above studies
left only three studies in the analysis should therefore be interpreted
with marked caution.3.4. The effectiveness of CBT across differing age groups
Further subgroup analysis using self-report outcome measures was
not completed because our initial analysis indicated that CBT was not
superior to control conditions when used to treat either affective disor-
ders of symptoms associated with autism. While there were 16 studies
thatmade use of informant-report outcomemeasureswhen treating af-
fective disorders, none of these included adult participants, and only
one study looking at the treatment of symptoms related to autism in-
cluded adult participants. As such, a subgroup analysis based on infor-
mant-report outcome measures was not completed.
Subgroup analysis using clinician-rated outcome measures across
different age groups was possible, but only for studies that aimed to
treat affective disorders. Therewas substantial variability that appeared
due to genuine subgroup differences, rather than sampling error, I2 =
80.2%, p= 0.006, and a large combined effect size in favour of CBT for
studies involving children and adolescents, g = 0.95; 95% CI [0.55,
1.35], z = 4.64, p b 0.001, but not for studies involving adults,symptoms related to ASD based on clinician-rated outcome.
Fig. 8. Forest plot showing estimated treatment effect of CBT for symptoms related to ASD based on task-based outcomes.
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outliers (Chalfant et al., 2007; Wood et al., 2009) from the studies in-
volving children and adolescents resulted in a lower but signiﬁcant ef-
fect size, g = 0.67; 95% CI [0.42, 0.91], z = 5.28, p b 0.001. The
comparison between studies involving children, adolescents and adults
is inherently problematic and should be interpreted cautiously because
only two studies involving adults were included (Fig. 9).
3.5. Publication bias
Visual inspection of Funnel plots did not reveal signiﬁcant asymme-
try for self-reported outcome measures used within studies that aimed
to treat affective disorders. Fail-safe N was not calculated because CBT
was not superior to control conditions. A similar analysis could not be
completed for studies that focused on symptoms related to autism be-
cause there were less than ten.
Turning to informant-based outcome measures, used for both stud-
ies that focused on affective disorders and symptoms associated with
autism, no signiﬁcant asymmetrywas found. For studies involving affec-
tive disorders, 281 new studies averaging a null result would be re-
quired to bring the overall treatment effect to non-signiﬁcance. For
studies targeting symptoms related to autism, 287 new studies averag-
ing a null result would be needed to again bring the overall treatment
effect to non-signiﬁcance. Theseﬁgures exceed 5n+10, and the conclu-
sion that these ﬁndings are robust to publication bias is valid.Fig. 9. Forest plot showing estimated treatment effect of CBT for thConsidering clinician-rated outcome measures, there was no signif-
icant asymmetry for studies that treated affective disorders, while a
Funnel plotwas not created for studies that treated symptoms of autism
because there were fewer than ten. Fail-safe N revealed that 227 new
studies averaging a null result would be needed to bring the treatment
effect to non-signiﬁcance calculated using clinician-rated outcomemea-
sures taken from studies that treated affective disorders. The effect cal-
culated using clinician-rated outcome measures taken from studies
treating symptoms associated with autism would become non-signiﬁ-
cant if only 18 papers averaging a null effect were published suggesting
that this ﬁnding may be subject to publication bias and inﬂuenced by
the fewer papers in this area.
Whilst it was not possible to examine task-based outcomemeasures
for studies that treated mental disorder, for studies that focused on
symptoms related to autism, because the number of papers was less
than ten, a Funnel plot could not be created. However, fail-safe N re-
vealed that only 5 new studies averaging a null effect size would bring
the overall treatment effect to non-signiﬁcance. This means that publi-
cation bias may feature, and the conclusions are heavily inﬂuenced by
there being relatively few papers.
4. Discussion
The results of themeta-analysis indicated that cognitive behavioural
therapy (CBT) is associated with a small to medium effect size whene treatment of affective disorders across different age groups.
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or adults who have ASDs, but this varied according to whether the out-
come data was taken from self-report, informant-report, clinician-re-
port, or task-based measures. CBT was associated with a small and
non-signiﬁcant effect size, g= 0.24, when the analysis was completed
using self-report measures, and associated with signiﬁcant heterogene-
ity; when studies at risk of bias were excluded, resulting in low hetero-
geneity, treatment was associated with a small non-signiﬁcant effect
size, g=0.09. CBTwas superior to control conditionswhen the analysis
was completed with either informant- and clinician-report measures,
both being associated with a medium effect size, but there was signiﬁ-
cant heterogeneity; a sensitivity analyses reduced heterogeneity, and
revealed that CBT remained superior, and was associated with a medi-
um effect size of, g= 0.45, and, g= 0.59, respectively.
Turning to consider CBT for symptoms associated with ASDs, the
ﬁndings from the meta-analysis were very similar to that found for
CBT when used to treat co-morbid affective disorders. CBT, when used
as a treatment for the symptoms of ASDs, rather than affective disorders,
was associated with an effect size that ranged from small to medium,
again, dependent upon the type of outcome measure used. Using data
from self-report measures, CBT was associated with a small non-signif-
icant effect size, g= 0.25, and while heterogeneity was not signiﬁcant,
excluding studies at risk of bias to reduce heterogeneity reduced the ef-
fect size; it remained small and non-signiﬁcant, g= 0.1. There was ev-
idence that CBT was signiﬁcantly beneﬁcial when the analysis was
based on informant-report measures, and resulted in a small effect
size, g = 0.48, which increased to medium following our sensitivity
analysis to account for heterogeneity, g= 0.52. Considering clinician-
report measures, CBTwas found to be signiﬁcantly superior, and associ-
ated with a medium effect size, g = 0.65. Following the exclusion of
studies thought to be at risk of bias to reduce heterogeneity, CBT was
no longer superior, and associatedwith a non-signiﬁcantmedium effect
size, g=0.44. Task-based measures, which are both less subjective and
completed by the participant, were also evaluated to determinewheth-
er CBT is an effective treatment for symptoms of ASDs. The initial ﬁnd-
ings were signiﬁcantly in favour of CBT as an effective treatment, and
associatedwith a small effect size, g=0.35, but the exclusion of studies
thought to be at higher risk of bias, led to a non-signiﬁcant treatment ef-
fect, falling in the small range, g= 0.3.
Sub-group analysis based on the age of the participants was not
completed for self-report measures as there was no evidence that CBT
was superior to control conditions, nor was this possible for infor-
mant-based measures, as few studies involving adults also included an
informant-based measure. It was only possible to undertake a sub-
group analysis for the treatment of affective disorders based on clini-
cian-report measures, and the ﬁndings indicated that CBT was superior
and associated with a large effect size, g = 0.95, when used with chil-
dren and adolescents, while following our sensitivity analysis, this re-
duced to a medium effect size, g = 0.67. These effect sizes are lower
than that previously reported by Sukhodolsky et al. (2013) and
Kreslins et al. (2015), with both previous meta-analyses having includ-
ed fewer studies. Turning to consider adults, the results indicated that
CBT was not superior to control conditions, and was associated with a
small effect size, g = 0.04; interpreting this result is problematic be-
cause it is only based on two published studies.
Within the current meta-analysis, and those completed previously
which focused on the treatment of anxiety amongst children and ado-
lescents (Kreslins et al., 2015; Sukhodolsky et al., 2013; Ung et al.,
2014), there are substantial differences in treatment efﬁcacy dependent
upon the type of outcomemeasure includedwithin the analysis. Self-re-
port measures, in contrast to informant- and clinician-report measures,
are not reliably associated with signiﬁcant change following treatment.
Within the currentmeta-analysis, thiswas the case for studies involving
children, adolescents or adults who received treatment for affective dis-
orders more broadly. This was also the case for studies where CBT was
used to treat the symptoms of ASDs. As discussed previously by bothSukhodolsky et al. (2013) and Kreslins et al. (2015) it may be the case
that individuals with ASDs have difﬁculties with reporting symptoms
because of associated developmental challenges (e.g. communication
problems) faced by this population leading to difﬁculties with reliably
reporting symptoms. Interestingly, Kreslins et al. (2015) suggested
that children with ASDs may confuse symptoms of anxiety and ASDs,
which may lead to difﬁculties with completing self-report measures of
anxiety. However, it is apparent that adults with ASDs also have these
difﬁculties, as while there are few trials involving adults, those that
have been completed had similar difﬁculties with the use of self-report
measures. Alongside this, trials of CBT used to treat symptoms of ASDs,
rather than affective disorders, have also encountered similar difﬁcul-
ties with self-report measures. It is perhaps probable that individuals
with ASDsmay ﬁnd self-report measures difﬁcult because of their asso-
ciated developmental problems (e.g. perspective-taking, communica-
tion problems) and further work regarding the development of valid
and reliable measures for use with this population is needed. However,
itmust also bementioned that perhaps CBTdoes not bring about change
for individuals with ASD, and the results using both informant- and cli-
nician-report measures have been subjected to an observer-expectancy
effect, considering that is very difﬁcult to mask informants, and not all
studies made use of masked assessors, introducing signiﬁcant bias.
While this may not explain all the variability within the data, it has a
role to play, and as such, it is vitally important that future trials ensure
that they make use of masked assessors and have satisfactory arrange-
ments for independent data management.
Related to these difﬁculties, there were a variety of issues associ-
ated with the included studies, highlighted by the quality appraisal,
which need to be considered further. First, themajority of the studies
included involved small samples, and trials labelled as feasibility or
pilot trials often had larger sample sizes than studies that were not
identiﬁed as either a feasibility or pilot trial. Eight of the studies in-
cluded in this meta-analysis had less than ten participants per
group. This is problematic, as there are no large scale deﬁnitive trials
in this area making use of robust methodologies. As such, the conclu-
sions reached within this meta-analysis, and previous meta-analyses
are potentially limited. This does not mean that the conclusions are
entirely invalid, but it does allow some questions to be raised about
validity, which could be addressed in the future with the completion
of several large scale deﬁnitive trials by different research groups
around the world. Related to these issues, the study by Chalfant et
al. (2007) tended to have a relatively higher standardised mean dif-
ference. While this was a randomised trial, the accessors were not
masked, and in fact were the actual therapists who carried out the in-
tervention. Considering the lack of blinding and independent data
management within this study, there is an inherent increased risk
of bias. Several other studies included within this meta-analysis
also had a relatively higher standardised mean difference (e.g.
Wood et al., 2009), and the majority of them did not make use of in-
dependent data management and analysis, something we would
strongly recommend for future trials in this area.
Second, studies often did not report sufﬁcient information regarding
participant engagement and ﬁdelity, while third, there were issues with
adequate allocation concealment that must be addressed within future
studies. Fourth, it is important to note that ten studies were not
randomised, and few reported that dataweremanaged and analysed in-
dependently. Fifth, and again looking forward to the future, researchers
in this area need to specify a primary outcomemeasure within their tri-
als, and further work to develop valid and reliable measures of outcome
for use with participants who have ASDs is needed. Sixth, it would be
advantageous for researchers to describe their interventionsmore thor-
oughly or ensure that they are available for scrutiny, perhaps within
public databases. Finally, it is recommended that future trials make
use of and adhere to the CONSORT recommendations for reporting
randomised control trials to help increase the quality of the evidence
that is available.
52 L. Weston et al. / Clinical Psychology Review 49 (2016) 41–54There are a number of strengths associated with the current meta-
analysis. Considering strengths, within the current meta-analysis, we
attempted to include studies that aimed to treat affective disorders
more broadly, rather than just anxiety, and included studies that were
designed to evaluate CBT as a treatment for the actual symptoms or
core features of ASDs. As such, our work is comprehensive, capturing
studies that have attempted to make use of CBT with individuals with
ASDs for a variety of problems and this is a marked strength over and
above previously completed meta-analytic work. Alongside this, we
have included studieswith samples of children, adolescents, and adults,
ormixed samples,while at the same time, undertaking a subgroup anal-
ysis to compare differences between children/adolescents and adults,
considering the developmental differences between these populations
which may have an impact upon the process of engaging in and com-
pleting therapy.We have alsomade use of an appropriate analytic strat-
egy, andmade use of independent reviewers for both screening and the
quality appraisal. As such, the current meta-analysis is the most com-
prehensive to date, covering CBT used to treat either affective disorders
or symptoms of autism.
Turning to considerweaknesses, there are a variety of problemswith
many of the included studies which have been mentioned in the pre-
ceding paragraph, and these problems need to be considered when
interpreting the results of thismeta-analysis.While this does not neces-
sarily invalidate our conclusions, it must be considered when
interpreting the ﬁndings and considering future research.
We would suggest that future studies in this area adhere to follow-
ing recommendations, (a) small-scale studies should be clearly de-
scribed as feasibility or pilot trials, (b) methods and interventions
should be described fully, in line with CONSORT recommendations.
Standardised reporting and a more uniform approach to study design
would help to minimise heterogeneity across studies, (c) appropriate
allocation concealment, randomisation, blinding procedures and inde-
pendent data management should be considered a priority and should
be described fully, (d) where possible, consistent usage of pre-existing
outcome measures across studies would be beneﬁcial in order to in-
crease comparability across trials, (e) researchers should specify a pri-
mary outcome measure a priori, and (f) participant engagement and
ﬁdelity should be clearly reported. Looking forward to the future, con-
sidering themarked number of small trials, well-designed deﬁnitive tri-
als from different research groups around theworld are needed in order
to demonstrate that CBT is an empirically validated treatment use with
people who have ASDs. To date, there has only been a single deﬁnitive
trial within this area (Freitag et al., 2015).
Bearing the aforementioned recommendations for future studies in
mind, and considering the conclusions from both the current and previ-
ous meta-analyses, CBT is at least associated with a small non-signiﬁ-
cant effect size, and at best, associated with a medium effect size,
depending on whether you ask those receiving the treatment, those
supporting the treatment, or those delivering the treatment. There are
three further commentswewould like to add to help in the design of fu-
ture studies, including the interventions. First, there have been a variety
of modelling and pilot studies across different countries, but very few
researchers have developed interventions within the spirit of co-pro-
duction with people with autism and their families. Co-production
means working together with those who will receive the intervention
when developing and running a clinical trial to ensure that those who
are likely to receive the intervention have also genuinely helped design
the intervention. While some studies employed this, if used more com-
monly, such a strategy would lead to improved engagement and out-
comes, especially from the point of view of children and adults with
autism.
Second, many of the reviewed studies focused on delivering group-
based interventions for a variety of different problems.While delivering
interventions in a groupmay bemore cost effective, this may not be as-
sociated with greater effectiveness. The reason for this is that co-mor-
bidity is high amongst people with autism, and within a group theremay be participants who have obsessive-compulsive disorder, social
phobia, generalised anxiety disorder, depression, or many other psychi-
atric problems, in addition to the difﬁculties associated with autism it-
self. While there are marked similarities, cognitive behavioural
therapy for depression is different than cognitive behavioural therapy
for obsessive compulsive disorder, and delivering interventions within
a group may have prevented therapists form being able to tailor the in-
tervention to address the needs of each individual within the group ad-
equately. Related to this, there are some individualswith ASDswhomay
be unable or unwilling to access group-based interventions. As such, we
recommend that researchers begin to focus more heavily on formula-
tion-driven and trans-diagnostic interventions delivered with individ-
uals, rather than within a group, bearing in mind that there is
evidence that individually delivered CBT is associated with stronger ef-
fect sizes than group-based CBT for people with intellectual disabilities,
another groupwhich tends to havemarked co-morbidity (Vereenooghe
& Langdon, 2013).
Finally, little to no attention has been paid to therapist competence
within this area, including therapist style, integrity, alliance and experi-
ence, all of which has been linked to outcomes in a variety of studies in-
volving people without ASDs (Brown et al., 2013; Haug et al., 2016;
Muse &McManus, 2013; Podell et al., 2013). Further research is needed
into these factors within studies involving people with ASDs in order to
potentially help improve outcomes. Related to this, little attention has
been paid to the accreditation of cognitive behavioural therapistswithin
the literature.While behavioural therapists are certiﬁed through the Be-
haviour Analyst Certiﬁcation Board®, those offering cognitive behav-
ioural therapy are not certiﬁed in a similar manner in many
jurisdictions. In some countries, such as the United Kingdom, there are
organisations which accredit cognitive behaviour therapists, namely
the British Association for Behavioural and Cognitive Psychotherapies
(BABCP), but this does not mean that therapists have appropriate clini-
cal expertise and experience of working with people who have ASDs in
order to ensure that they are able to adapt therapy in away that is likely
to be efﬁcacious. Further, while CBT should be adapted to meet the
needs of those with ASDs, we still know relatively little about the effec-
tiveness of many of these adaptations, as they have not been investigat-
ed using experimental designs to determine whether they lead to
substantial improvements in treatment engagement and outcome.
While future deﬁnitive trials are certainly needed within this area,
alongside this, we also need greater experimental work examining the
effectiveness of various adaptations to CBT for use with people who
have ASDs.
Appendix A and B. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.cpr.2016.08.001.
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